OECD Analyses Economic Effects of Counterfeiting and Piracy of Pharmaceuticals

GMP News
30 May 2007

OECD Analyses Economic Effects of Counterfeiting and Piracy of Pharmaceuticals

In response to rising concerns by government and the business community, the Organisation for Economic Co-operation and Development (OECD) has launched a project to assess the effects of counterfeiting and piracy on economies. The objective of the project is to improve factual understanding and awareness of the effects that counterfeiting and piracy of intellectual property rights have on governments, business and consumers. This project will focus on counterfeit and pirated products from an intellectual property perspective (i.e. tangible products that infringe trademarks, copyrights, patents and design rights.

Within this project, a number of sectoral case studies will be conducted, illustrating the various forms of counterfeiting and piracy, and the effects on producers, consumers and governments. The pharmaceutical sector has been identified, since counterfeiting of medicines has significant safety, health, social and economic implications. A sector report on the counterfeiting and piracy of pharmaceuticals will be part of the OECD project. A separate and second report focusing solely on the counterfeiting of pharmaceuticals, from a broader, public-health perspective, is also being produced. The report will examine the diverse definitions of counterfeit pharmaceuticals, the nature and scope of counterfeiting activities, and the procedures used. It will assess the trends and magnitude, evaluate the impacts on patients/consumers (especially public health implications) on the private sector and on governments. It will analyse measures employed for combating counterfeiting of pharmaceuticals. Anticipated publication in 2007.

Source: OECD Health Update, Issue No.3, May 2007

Hear representatives from MHRA and WHO speak at the ECA Conference

in Vienna, Austria from 19 – 20 June 2007.

Also specialists from the pharmaceutical industry and service providers will share their expert knowledge about all relevant aspects regarding the current expectations and the actual development in Good Distribution Practice, Cold Chain Management and Anti-Counterfeiting Strategies.

Wolfgang Schmitt
On behalf of the European Compliance Academy (ECA)

Go back

GMP Conferences by Topics